1 / 31

COMMON INFECTIOUS DISEASES IN LABORATORY RATS AND MICE

COMMON INFECTIOUS DISEASES IN LABORATORY RATS AND MICE. What’s common?. Helicobacter spp. – 15% C. bovis – 3% Pneumocystis carinii – 2% Pinworms – Mouse – 0.3% Rat – 1.3% Mites – 0.1% (mice only). MHV – 2% Parvoviruses Mouse – 2% Rat – 4% EDIM – 0.7% Norovirus ~30% RRV – 7%.

lois-nieves
Télécharger la présentation

COMMON INFECTIOUS DISEASES IN LABORATORY RATS AND MICE

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. COMMON INFECTIOUS DISEASES IN LABORATORY RATS AND MICE

  2. What’s common? • Helicobacter spp. – 15% • C. bovis – 3% • Pneumocystis carinii – 2% • Pinworms – Mouse – 0.3% Rat – 1.3% • Mites – 0.1% (mice only) • MHV – 2% • Parvoviruses • Mouse – 2% • Rat – 4% • EDIM – 0.7% • Norovirus ~30% • RRV – 7%

  3. What’s common in mice?

  4. What’s common in rats?

  5. Mouse Hepatitis Virus(MHV) • Coronavirus, ss RNA, enveloped • Very high evolutionary capacity (innumerable strains) • Prevalence moderate • Virus types grouped as enterotropic (intestinal) or polytropic (multiple tissue) – most field strains are enterotropic • Clinical signs very rare in immunocompetent mice after weaning • Wasting syndrome in many immunodeficient mice

  6. MHV • As enveloped virus – does not persist in environment. Probably not infective after 48 hrs. • Short-term transfer by fomites (sleeves, equipment, bedding) • Highly contagious and can spread rapidly

  7. Enterotropic MHV • Strains: D, RI, Y, G, myriad others. • Most wild type strains are enterotropic • Clinical signs and gross lesions rare in immunocompetent adult mice • Primary replication: • GI tract, especially distal ileum, cecum, ascending colon • Secondary sites - uncommon • Clearance mediated by B cells • Not cleared in μMT mice (anecdotally also in many GM lines) • Dissemination prevented by T cells • Disseminates in TCR βδ- , IFN-γ- , RAG1, athymic nude mice

  8. Research Impact of MHV • Prolonged immunologic effects: • NK cells, T-cells, B-cells • Infects monocytes, macrophages, bone marrow dendritic cells • Delayed allogeneic graft rejection • Alters course of concurrent infections, such as Helicobacter hepaticus

  9. MHV Detection • Serology • Excellent cross-reaction among strains • MFIA or ELISA, with IFA for confirmation • Seroconversion within 2 weeks (often one week) • Histopathology • Lesions should by confirmed by IHC, PCR or serology

  10. MHV Diagnosis • PCR • Sequencing of PCR product (nucleocapsid gene) for epidemiology • Fecal Shedding (quarantine, immunodeficient mice) • Environmental • Confirmation of serology by PCR of mesenteric lymph nodes

  11. CONTROL OF MHV • Immunocompetent mice self-cure • Enveloped virus: not stable in environment, easy to disinfect • Can eliminate from immunocompetent colonies by not breeding and no new mice for 6-8 weeks (test 1st) • Infection persists in immunodeficient mice

  12. Parvoviruses Are you getting mixed signals on parvoviruses?

  13. Parvoviruses in Mice • ssDNA, non-enveloped • Virus remains active in environment • Resistant to desiccation and many (non-oxidizing) disinfectants • Fairly common • Generally no clinical signs • Cause persistent infection – no self-cure • Need actively dividing cells to replicate

  14. Parvoviruses of Mice • Mice Minute Virus (MMV or MVM) • Multiple strains (i, p, c, m), MMVm is most prevalent and is persistent. Others are culture-adapted strains. • MMVm reported to cause stunting, low reproduction and early deaths in NOD μ-chain KO mice. • Experimentally, caused hronic progressive infection in scid mice.

  15. Research Effects of MMV • Cell culture • Can infect many mouse cell lines, as well as some rat embryo lines and transformed human cells (324K, EL-4) • Immunity • In vitro reduction of T-cell response by MMVi and in vivo late reduction of cytotoxic memory cells by MMVp • Cytoskeleton • In vitro (A9 cells) dysregulation of gelsolin (↑) and WASP (↓) by MMVp • Tumor studies • MMVp is oncotropic and oncolytic in some human tumors (hemangiosarcoma) and mouse tumors

  16. Parvoviruses of Mice • Mouse Parvovirus (MPV-1, MPV-2, MPV-3, MPV-4) • Prevalence higher than MMV • Causes persistent infection • No anatomic lesions, even in scid mice • Different strains not very cross-reactive by ELISA, MFIA • C57BL/6 mice and congenic strains partially resistant to infection • C57BL/6 mice require 10-100x infective dose • DBA/2 only slightly better

  17. Research Effects of MPV • MPV-1a (cell culture adapted) modulates immune response (McKisic et al, 1996) • Suppression of T cell response in vitro • CD8+ T lymphocyte clones lose function and viability • Cytokine- and antigen-induced T cell proliferation in vitro suppressed after exposure to MPV-1a • Potentiates allograft rejection in vivo • GEM expressing B19 NS1 have altered immune system and high fetal mortality resembling non-immune hydrops fetalis

  18. Detection of Parvoviruses • Serology – Usually best for screening • MFIA or ELISA - Traditional or recombinant antigens • Use panel of antigens for each serotype, plus the generic NS-1 antigen • Mice - MMV, MPV-1, MPV-2, and NS-1 • Rats - RV, H-1, RPV, RMV and NS-1 • IFA – Good follow-up assay for positive/equivocal MFIA/ELISA • Be careful with MPV serology of C57BL/6 mice!

  19. Detection of Mouse Parvoviruses • PCR • Can be strain-specific (VP2) or generic (NS-1) • Mesenteric LN stay positive indefinitely • Pooled fecal samples to detect shedding (Beware of fecal inhibitors of PCR) • Biologicals and cell cultures • Environmental swabs

  20. Detection of Mouse Parvoviruses • Many Challenges (sentinel parvovirus) • Some strains partially resistant (C57BL/6, DBA/2) • Not all mice may seroconvert to all antigens (NS-1) • May have very low prevalence in IVC and filter-top caging (hard to sort out from false positives) • Seroconversion generally within 7 days, but may be slow in adults exposed to low infectious dose

  21. Control of Parvoviruses • Can not “burn out” because infection is persistent • Can only eliminate by rederivation • If caesarian section, must carefully test offspring and foster dams. Primaparous dams more likely to be viremic. • Reported as detected from sperm and pre-implantation embryos • No envelope, so it stays active in environment • Must thoroughly disinfect environment, materials and equipment with oxidizing agent (Clidox, ozone, etc.)

  22. Exclusion of Parvoviruses • Consider sources of research animals: • Vendors, GM animals, immunodeficient • Wild rodents • Biological materials • Risk from personnel handling infected rodents (pets, snake food) • Fomites (Feed, bedding, water, used/shared equipment etc.)

  23. Noroviruses • Type virus is Norwalk virus, “cruise ship virus” • Non-enveloped, RNA • Cause >90% nonbacterial epidemic gastroenteritis worldwide, 23M cases/yr in US (per CDC) • Cruise ships, institutions, military

  24. Noroviruses • MNV • Genetically distinct (genogroup V) from human noroviruses (I, II, IV), zoonotic spread unlikely • No evidence of clinical disease or lesions in immunocompetent mice • No noroviruses yet reported in other lab rodents

  25. MNV-1 • No disease in immunocompetent mice • High mortality in RAG (-/-) STAT (-/-)double KO mice, with disseminated infection and encephalitis and pneumonia • Encephalitis only with IC inoculation

  26. MNV • Many variants isolated at this point, > 50 at CRL • MNV widespread in lab mouse research facilities • No clinical disease reported in natural infections • Most major vendors (including CRL) reporting all colonies negative for MNV by serology and/or PCR

  27. MNV • Research interference unknown, but: • MNV-1 was detected in macrophage-like cells in vivo and grew in vitro in dendritic cells and macrophages. Growth was inhibited by the interferon αβ receptor and by STAT-1 (Wobus et al., 2004) • Possible macrophage aggregates in RAG livers

  28. MNV • Diagnosis: • MFIA/ELISA – recombinant capsid protein self-assembles into VLP. Good cross-reaction among variants • PCR – Virus shed in feces for long periods, should persist in environment. PCR must be properly designed to be able to detect multiple strains.

  29. MNV • Management • Virus probably present in mice for a long time (so no hurry) • Nonpathogenic • Widely distributed • Numerous strains • Noroviruses should not cross placenta, so c-section or ET rederivation should be successful • Must consider environmental decontamination

More Related